Cargando…
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids
Most clinically used opioids are thought to induce analgesia through activation of the mu opioid receptor (MOR). However, disparities have been observed between the efficacy of opioids in activating the MOR in vitro and in inducing analgesia in vivo. In addition, some clinically used opioids do not...
Autores principales: | Olson, Keith M., Duron, David I., Womer, Daniel, Fell, Ryan, Streicher, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553708/ https://www.ncbi.nlm.nih.gov/pubmed/31170174 http://dx.doi.org/10.1371/journal.pone.0217371 |
Ejemplares similares
-
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain
por: Olson, Keith M., et al.
Publicado: (2017) -
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
por: Victorri-Vigneau, Caroline, et al.
Publicado: (2018) -
The Alpha Isoform of Heat Shock Protein 90 and the Co-chaperones p23 and Cdc37 Promote Opioid Anti-nociception in the Brain
por: Lei, Wei, et al.
Publicado: (2019) -
The role of opioid receptors in modulating Alzheimer’s Disease
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2023) -
Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)